Specific cardiomyopathy in lupus patients: report of three cases

Moder, 1999, Cardiac involvement in systemic lupus erythematosus, Mayo Clin Proc, 74, 275, 10.4065/74.3.275

Fairfax, 1988, Endomyocardial biopsy in patients with systemic lupus erythematosus, J Rheumatol, 15, 593

Vaarala, 1995, Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men, Circulation, 91, 23, 10.1161/01.CIR.91.1.23

Asherson, 1991, Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist, Circulation, 84–92, 920, 10.1161/01.CIR.84.2.920

Naarendorp, 1999, Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases, J Rheumatol, 26, 2257

Mason, 1995, A clinical trial of immunosuppressive therapy for myocarditis, NEJM, 333, 269, 10.1056/NEJM199508033330501

Borenstein, 1978, The myocarditis of systemic lupus erythematosus. Association with myositis, Ann Intern M, 89, 619, 10.7326/0003-4819-89-5-619

Estes, 1987, Chloroquine neuromyotoxicity. Clinical and pathologic perspective, Am J M, 82, 447, 10.1016/0002-9343(87)90444-X

Bulkley, 1975, The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy; a study of 36 necropsy patients, Am J M, 58, 243, 10.1016/0002-9343(75)90575-6

Petri, 1992, Risk factors for coronary artery disease in patients with systemic lupus erythematosus, Am J M, 93, 513, 10.1016/0002-9343(92)90578-Y

Morguet, 1995, Indium-111-antimyosin Fab imaging to demonstrate myocardial involvement in systemic lupus erythematosus, J Nucl M, 36, 1432